Document is current
Any future updates will be listed below
-
Authors
Wen, Timothy
Faye, Adam S. https://orcid.org/0000-0002-1571-5856
Lee, Kate E.
Friedman, Alexander M.
Wright, Jason D.
Lebwohl, Benjamin
Colombel, Jean-Frederic
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32DK083256-12S1)
- License Information
-
More Information
Article History
Received: 13 January 2021
Accepted: 10 April 2021
First Online: 1 May 2021
Declarations
:
: ASF, TW, AMF: None. KEL: NIH: T32DK083256-12S1. JDW: Dr. Wright reports receiving research grants from Merck and is a consultant for Clovis Oncology. BL: The Louis and Gloria Flanzer Philanthropic Trust. JFC: Dr. Colombel reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Geneva, Genentech, Janssen Pharmaceuticals, Landos, Limma Tech Biologics AG, Ipsen, Imedex, Immunic, lmtbio, Medimmune, Merck, Novartis, O Mass, Ostuka, Pfizer, SERENE CD, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit.
